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ABSTRACT
A challenge of targeting glutamine metabolism in cancer is that tumor cells develop various strategies to
adapt to glutamine limitation. We found that asparagine plays a critical role in supporting protein
synthesis during glutamine starvation, highlighting a possible approach to optimize the therapeutic
efficacy of targeting glutamine metabolism in cancer. KEYWORDS
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Glutamine functions as a versatile donor of nitrogen and
carbon atoms to support biosynthetic and bioenergetic reac-
tions in proliferating cells.1 However, glutamine levels in tumor
environment are frequently found to be depleted under physio-
logical conditions.2 Thus, how tumor cells adapt to glutamine
depletion becomes an important topic, particularly in term of
developing novel therapeutic strategies that target glutamine
uptake/metabolism. Along this line, we previously reported
that exogenous supply of asparagine, a nonessential amino
acid, is sufficient to rescue cell survival in tumor cells that
undergo apoptosis during glutamine withdrawal.3 Furthermore,
this effect of rescue does not require restoring the tricarboxylic
acid (TCA) cycle anaplerosis or other nonessential amino
acids, both of which are routinely maintained via glutamine
catabolism.3 Since a chemical inhibitor of glutamine metabo-
lism has entered clinical trials in cancer patients,1 understand-
ing the mechanism by which asparagine mediates cellular
adaptation to glutamine limitation will be crucial to interpret
the therapeutic responses.
In our recent study, we reported that the effect of asparagine
to rescue glutamine deficiency is a generalizable phenomenon
across a broad panel of tumor cell lines. In some cell lines,
asparagine can even rescue proliferation defect during gluta-
mine depletion.4 Indeed, when exogenous glutamine is
depleted, most mammalian cell lines are competent of synthe-
sizing glutamine de novo to support the biosynthesis of
nucleotides and nonessential amino acids, with the exception
of asparagine. As a result, the reason that asparagine rescues
cell proliferation during glutamine starvation is only due to the
ability of asparagine to support protein synthesis (Fig. 1).4
Unlike unicellular organisms, all tested mammalian cell lines
lack cytosolic asparaginase activity to catabolize asparagine to
fuel biosynthetic pathways. Interestingly, restoration of aspara-
ginase activity in mammalian cells by using yeast or zebrafish
orthologues can fully restore the capacity of mammalian cells
to use asparagine as a biosynthetic substrate to support the
TCA cycle anaplerosis, nucleotide biosynthesis, and even the
synthesis of glutamine itself. However, under physiological lev-
els of environmental asparagine, usually below 0.1 mM as it has
been shown in human plasma, expression of zebrafish
asparaginase (zASPG) suppresses cell growth and survival in
glutamine-deficient medium in vitro and compromises xengraft
tumor growth in vivo, which results from the depletion of intra-
cellular asparagine. These results suggest that asparagine is a
critical limiting metabolite during glutamine restriction, and
lack of asparaginase activity may represent an evolutionary
strategy that mammals use to adapt to pathophysiological var-
iations of extracellular glutamine.
Glutamine metabolism has been extensively studied recently
due to its versatile usage to support biosynthesis and bioener-
getics beyond its role as an amino acid for protein synthesis.2
Pioneer works showed that glutamine catabolism to glutamate
and consequently to a-ketoglutarate is essential for glutamine-
dependent cell growth and survival.5,6 This is because a-keto-
glutarate is a TCA cycle intermediate and glutamine-derived
a-ketoglutarate fuels the TCA cycle to replenish the precursors
that are consumed during various biosynthesis. Our results
challenge this traditional paradigm by showing that asparagine
can rescue glutamine-depletion-induced cell death or growth
arrest without restoring the TCA cycle anaplerosis. Indeed,
CONTACT Ji Zhang jzh1@iu.edu. 1044 W Walnut Street, R4-170, Indianapolis, IN 46202 USA.
© 2018 Jie Jiang, Natalya N Pavlova, and Ji Zhang. Published with license by Taylor & Francis Group, LLC
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
MOLECULAR & CELLULAR ONCOLOGY
2018, VOL. 5, NO. 3, e1441633 (2 pages)
https://doi.org/10.1080/23723556.2018.1441633
most mammalian cells are competent to use glucose-derived
carbon to fuel the TCA cycle when extracellular glutamine
becomes limited, which is sufficient to drive the a-ketoglutarate
efflux to support the biosynthesis of glutamate and glutamine.
However, this efflux from the TCA cycle is not sufficient to
drive the biosynthesis of asparagine, therefore leading to an
inhibition of global protein synthesis. Notably, in addition to
restoring intracellular asparagine, exogenous supply of aspara-
gine dramatically induces the accumulation of glutamine
synthetase (GLUL) protein at a post-transcriptional level. To
demonstrate the critical role of glutamine biosynthesis, we used
both pharmacological inhibition and CRISPR/Cas9-mediated
genomic editing technology to confirm that GLUL is
required for asparagine-dependent rescue of cell proliferation
during glutamine starvation.
Recent works have also demonstrated a critical role of intra-
cellular aspartate to support nucleotide biosynthesis.7,8 Indeed,
unicellular organisms can catabolize asparagine to produce
aspartate through cytosolic asparaginase. But, we failed to detect
meaningful conversion of asparagine to aspartate in all the
tested mammalian cell lines, probably because of the lack of
asparaginase activity.4 In contrast, cell lines derived from fruit
fly or zebrafish readily convert asparagine to aspartate even
beyond the levels it is routinely maintained through glutamine
catabolism. Interestingly, ectopic expression of two human
orthologues of asparaginase did not confer meaningful asparagi-
nase activity in the assays we tested. These findings imply that
the asparaginase activity may be lost during late evolution,
which can be co-evolved with the decrease of environmental
asparagine levels. Therefore, asparagine is evolutionarily selected
to be preserved rather than to be consumed for the production
of aspartate, as the latter can be synthesized from the TCA cycle
intermediate—oxaloacetate—via transamination (Fig. 1).
Therapeutic Outlook
An inhibitor of glutaminase that converts glutamine to gluta-
mate has entered clinical trials in cancer patients.9 Our results
suggest that tumor cells’ response to glutaminase inhibitor may
be dictated by environmental levels of asparagine. Along this
line, bacteria-derived L-asparaginase has been used for decades
to treat childhood lymphoblastic leukemia through depleting
the circulating asparagine.10 Thus, combination of the gluta-
minase inhibitor with L-asparaginase treatment may be a
potential strategy to maximize the therapeutic efficacy. Further-
more, glutamine biosynthesis should also be explored as a
potential therapeutic target, as our results indicate its indis-
pensable role for tumor cell growth when exogenous glutamine
is limited.
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Figure 1. Key role for asparagine in protein synthesis during glutamine starvation.
Most mammalian cells can maintain the TCA cycle anaplerosis and sustain gluta-
mine biosynthesis de novo when environmental glutamine is restricted. However,
asparagine biosynthesis is abolished under this condition, rendering cells to rely
on exogenous supply of asparagine to support protein synthesis. Gln: glutamine;
Asp: aspartate; Asn: asparagine; Glc: glucose; NEAA: nonessential amino acid; TCA:
tricarboxylic acid.
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